Key facts
- This page summarizes Robert John Andrew Ryan's Form 4 filing for ASP Isotopes Inc. (ASPI).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 22 Dec 2025, 21:02.
Robert John Andrew Ryan - 18 Dec 2025 Form 4 Insider Report for ASP Isotopes Inc. (ASPI)
- Reporting relationship
- Director
- Issuer ticker
- ASPI
- Reported as of
- 18 Dec 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 22 Dec 2025, 21:02:21 UTC
- Prior SEC filing
- 14 Feb 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Donald Ainscow, as attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Robert John Andrew Ryan filed Form 4 for ASP Isotopes Inc. (ASPI) on 22 Dec 2025.
Change
- Previous filing in this sequence was filed on 14 Feb 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0002011790
Primary reporting owner
Ryan Robert John Andrew
- Relationship
- Director
- Address
- ASP ISOTOPES INC. 601 PENNSYLVANIA AVE, NW STH BLDG STE 900, WASHINGTON
- Signature
- /s/ Donald Ainscow, as attorney-in-fact
- Signature date
- 22 Dec 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ASPI
transaction
Common Stock
Award
- Transaction value
- Shares
- +36,548
- Change %
- +5.9%
- Price
- Shares after
- 652,222
- Date
- 18 Dec 2025
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Annual award of shares of restricted stock in connection with the reporting person's service as an independent director of ASP Isotopes Inc.